KAS109

GSKY - BLUE Skies for GSKY?

Long
KAS109 Updated   
NASDAQ:GSKY   None
If this can break through resistance @ $11.35 and resolve the gap @ $12.04, then I would be a buyer. Has support from the 10 and 20 ema, but will it hold? No position here. Any positive news might give it the juice it needs.

Risks:
Class action lawsuit
stagnation

From Forbes:
David Zalik is the cofounder and CEO of financial technology company GreenSky.
The Atlanta-based company has facilitated $13 billion in loans for home improvement projects via a network of banks and 13,000 contractors.
GreenSky has also begun to branch into financing for doctor, dentist and veterinary visits.
Zalik took the $325 million (sales) company public in May 2018.

From Yahoo Finance:
GreenSky increases patient access to elective healthcare by making dynamic, point of service promotional financing solutions available to a growing nation-wide network of strong clinical providers. GreenSky now offers the most comprehensive financing solution available in the industry. No peer offers both revolving credit and a full suite of extended term installment loan products,” said Dennis Kelly, President, GreenSky Patient Solutions®. “GreenSky provides a comprehensive and customized solution for practices and their patients, whether care is episodic in nature or recurring, utilizing installment loans and revolving credit, respectively.”

Trade active:
In @ $11.78, Stop = $10.14, 0.2% capital risk, small share size
Comment:
Possible add more shares here; ascending wedge pattern and 20 MA sloping up = good entry area. Will add at EOD based on today's closing action and FOMC meeting consequences.
Trade active:
Stop to $12.17
Trade active:
Consolidating, stop moved to $12.54
Comment:
Adding more shares today, 0.2% more
Trade active:
Stop = $13.76
Trade active:
Stop = $ 14. 71. Will trail the 10 day low until position takes itself out. No more updates here.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.